{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:10:52Z","timestamp":1773277852227,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.4158\/ep13059.or","type":"journal-article","created":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T22:40:01Z","timestamp":1378507201000},"page":"33-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Amiodarone-Induced Thyrotoxicosis in Adults with Congenital Heart Disease -Clinical Presentation and Response to Therapy"],"prefix":"10.1016","volume":"20","author":[{"given":"Marius N.","family":"Stan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matheni","family":"Sathananthan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole A.","family":"Warnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabin","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca S.","family":"Bahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP13059.OR_bb0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/CIRCULATIONAHA.106.627224","article-title":"Congenital heart disease in the general population: changing prevalence and age distribution","volume":"115","author":"Marelli","year":"2007","journal-title":"Circulation."},{"key":"10.4158\/EP13059.OR_bb0010","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0735-1097(01)01272-4","article-title":"Task force 1: the changing profile of congenital heart disease in adult life","volume":"37","author":"Warnes","year":"2001","journal-title":"J Am Coll Cardiol."},{"key":"10.4158\/EP13059.OR_bb0015","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/CIRCULATIONAHA.109.866319","article-title":"Atrial arrhythmias in adults with congenital heart disease","volume":"120","author":"Bouchardy","year":"2009","journal-title":"Circulation."},{"key":"10.4158\/EP13059.OR_bb0020","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.ijcard.2012.02.015","article-title":"Body mass index and the development of amiodarone-induced thyrotoxicosis in adults with congenital heart disease\u2014a cohort study","volume":"167","author":"Stan","year":"2013","journal-title":"Int J Cardiol."},{"key":"10.4158\/EP13059.OR_bb0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.CIR.100.2.149","article-title":"Amiodarone-associated thyroid dysfunction: risk factors in adults with congenital heart disease","volume":"100","author":"Thorne","year":"1999","journal-title":"Circulation."},{"key":"10.4158\/EP13059.OR_bb0030","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2007.02.054","article-title":"Amiodarone-induced thyrotoxicosis: clinical course and predictors of outcome","volume":"49","author":"Conen","year":"2007","journal-title":"J Am Coll Cardiol."},{"key":"10.4158\/EP13059.OR_bb0035","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1210\/jc.2010-0180","article-title":"Approach to the patient with amiodarone-induced thyrotoxicosis","volume":"95","author":"Bogazzi","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP13059.OR_bb0040","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.beem.2009.07.001","article-title":"Amiodarone and thyroid","volume":"23","author":"Eskes","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"10.4158\/EP13059.OR_bb0045","first-page":"2012","article-title":"A risk prediction index for amiodarone-induced thyrotoxicosis in adults with congenital heart disease","volume":"210529","author":"Stan","year":"2012","journal-title":"J Thyroid Res."},{"key":"10.4158\/EP13059.OR_bb0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-101-1-28","article-title":"Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy","volume":"101","author":"Martino","year":"1984","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP13059.OR_bb0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrendo.2009.225","article-title":"Effects of amiodarone therapy on thyroid function","volume":"6","author":"Cohen-Lehman","year":"2010","journal-title":"Nat Rev Endocrinol."},{"key":"10.4158\/EP13059.OR_bb0060","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2265.2007.02920.x","article-title":"Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy","volume":"67","author":"Bogazzi","year":"2007","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP13059.OR_bb0065","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1253\/jcj.65.958","article-title":"Amiodarone-induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan","volume":"65","author":"Shiga","year":"2001","journal-title":"Jpn Circ J."},{"key":"10.4158\/EP13059.OR_bb0070","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/ncpendmet0592","article-title":"Treatment of amiodarone-associated thyrotoxicosis","volume":"3","author":"Franklyn","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab."},{"key":"10.4158\/EP13059.OR_bb0075","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1365-2265.2008.03268.x","article-title":"Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists","volume":"69","author":"Tanda","year":"2008","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP13059.OR_bb0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.0300-0664.2001.01457.x","article-title":"Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography","volume":"56","author":"Eaton","year":"2002","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP13059.OR_bb0085","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1161\/circ.105.11.1275","article-title":"Successful treatment of amiodarone-induced thyrotoxicosis","volume":"105","author":"Osman","year":"2002","journal-title":"Circulation."},{"key":"10.4158\/EP13059.OR_bb0090","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2265.2011.04087.x","article-title":"Determinants and outcome of amiodarone-associated thyroid dysfunction","volume":"75","author":"Ahmed","year":"2011","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP13059.OR_bb0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/105072503321319521","article-title":"A stepwise approach to the treatment of amiodarone-induced thyrotoxicosis","volume":"13","author":"Erdogan","year":"2003","journal-title":"Thyroid."},{"key":"10.4158\/EP13059.OR_bb0100","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1530\/EJE-08-0348","article-title":"The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis","volume":"159","author":"Piga","year":"2008","journal-title":"Eur J Endocrinol."},{"key":"10.4158\/EP13059.OR_bb0105","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00268-004-7599-6","article-title":"Surgical management of amiodarone-associated thyrotoxicosis: Mayo Clinic experience","volume":"28","author":"Houghton","year":"2004","journal-title":"World J Surg."},{"key":"10.4158\/EP13059.OR_bb0110","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1210\/jc.2011-2390","article-title":"Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial","volume":"97","author":"Eskes","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP13059.OR_bb0115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2165\/00002018-200629030-00006","article-title":"Continuation of amiodarone therapy despite type II amiodarone-induced thyrotoxicosis","volume":"29","author":"Uzan","year":"2006","journal-title":"Drug Saf."},{"key":"10.4158\/EP13059.OR_bb0120","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1210\/jc.2011-1678","article-title":"Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: a pilot study","volume":"96","author":"Bogazzi","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP13059.OR_bb0125","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/BF03344178","article-title":"Long-term outcome of thyroid function after amiodarone-induced thyrotoxicosis","volume":"29","author":"Bogazzi","year":"2006","journal-title":"as compared to subacute thyroiditis. J Endocrinol Invest."},{"key":"10.4158\/EP13059.OR_bb0130","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1507\/endocrj.K06-027","article-title":"Mild and short recurrence of type II amiodarone-induced thyrotoxicosis in three patients receiving amiodarone continuously for more than 10 years","volume":"53","author":"Sato","year":"2006","journal-title":"Endocr J."},{"key":"10.4158\/EP13059.OR_bb0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0021-9681(79)90012-2","article-title":"Bias in analytic research","volume":"32","author":"Sackett","year":"1979","journal-title":"J Chronic Dis."},{"key":"10.4158\/EP13059.OR_bb0140","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.amjmed.2004.11.028","article-title":"Amiodarone and the thyroid","volume":"118","author":"Basaria","year":"2005","journal-title":"Am J Med."},{"key":"10.4158\/EP13059.OR_bb0145","first-page":"423","article-title":"Serum interleukin-6 in amiodarone-induced thyrotoxicosis","volume":"78","author":"Bartalena","year":"1994","journal-title":"J Clin Endocrinol Metab."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20435542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20435542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/H889838417X36744.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:57:47Z","timestamp":1761515867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20435542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1530891X20435542"],"URL":"https:\/\/doi.org\/10.4158\/ep13059.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amiodarone-Induced Thyrotoxicosis in Adults with Congenital Heart Disease -Clinical Presentation and Response to Therapy","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP13059.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}